Physician profile
Violet Klenov
NPI 1134484082
$1,646.23
in general payments reported to CMS, 2019-2025
8 companies · $305 in 2025
The $305 reported for 2025 was more than what 77% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $80.64 · 2021: $438 · 2022: $159 · 2023: $88.08 · 2024: $334 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $406.26 | 2021-2025 | Follistim Aq, Ganirelix Acetate |
| Ferring Pharmaceuticals INC. | $385.76 | 2019-2025 | Menopur |
| Coopersurgical, INC. | $350.71 | 2019-2025 | Origio Sequential Fert |
| Emd Serono, INC. | $184.91 | 2020-2024 | |
| Merck Sharp & Dohme LLC | $179.57 | 2019-2021 | |
| Hamilton Thorne, INC. | $76.62 | 2025 | Cook, Guardia, Lykos |
| Hologic Sales and Service, LLC | $47.61 | 2024-2025 | Third Wave, Aptima, Thinprep 2000 Processor |
| Vertical Pharmaceuticals, LLC | $14.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Violet Klenov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.